Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.
What to ask and expect when going for a memory, Alzheimer’s or dementia diagnosis.
WHEN DIAGNOSING DEMENTIA, NEUROLOGISTS KNOW that nothing is as important as spending time face-to-face. Understanding symptoms and clinical clues in exams are the critical aspects of neurology. Learn how America’s healthcare system holds up to this standard.
Alzheimer’s can cause difficulty falling asleep, staying asleep and awakening too early. These often lead to nighttime confusion and wandering. Doctors think they know why.
Beta-amyloid and tau proteins have long been considered the culprits behind Alzheimer’s. Yet many people have plenty of amyloid and tau protein, but no Alzheimer’s. Is TDP-43 the reason why?
There are myriad technologies that can be helpful in making life easier for people with dementia. Learn more.
85-year-old Betty Wallwork was diagnosed with Alzheimer’s. But it wasn’t true. Find out why.
Until now, scientists were unsure about how APOE4 creates the strongest genetic risk factor in Alzheimer’s. Now they believe they know.
Researchers say reading, writing letters, doing puzzles or playing card games in later life could delay the onset of Alzheimer’s by as much as five years.
We make a living by what we get,But we make a life by what we give. (Winston Churchill)
Clinical Psychology / Neuropsychology
LIFECARE PSYCHOLOGY GROUP, LLC
Empower yourself with a detailed report of your brain’s function, consisting of an assessment of your cognitive function and your brain connectivity with a quick 45-minute on-site appointment.
One woman held the genetic key to unlock the mystery of how she was the only one free of early-onset Alzheimer’s, out of 1,200 members of a South American family,
Researchers say it takes a dozen “intervention sessions” to improve cognition in those at risk for Alzheimer’s and other dementias.
FDA-approved Sargramostim, a normal human protein, improved memory and cognition in Alzheimer’s patients in a Phase II clinical trial. The drug is safe and well-tolerated, and has been used for other disorders for 30 years.
This carpool sing-a-long between a father with dementia and his son went viral. $50,000 in donations poured into the Alzheimer’s Society. Enjoy their great music. Sing along if you can!
No spam, only news and updates.
